STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Investor
Corporate Presentation Investor Relations, May 2015
Farmaceutica: il Gruppo STADA continua a crescere anche in tempi difficili
STADA and Alvotech broaden European patients' options by launching Hukyndra® high-concentration, citrate-free adalimumab - Alvotech
Press release: STADA ranks among top 10% of pharma firms on sustainability | Presseportal
Press release : STADA further grows its European Consumer Healthcare portfolio by ... | Presseportal
Financial Reports - Investor Relations | STADA
Investor Relations | STADA
Investor Relations | STADA
Investor Relations | STADA
Nidda Healthcare GmbH - Investor Relations
Press release: Zuellig Pharma becomes STADA Philippines' exclusive distribution partner | Presseportal
Investor Relations | STADA
Annual General Meeting 2020 - Investor Relations | STADA
STADA shows resilience with double-digit growth in 2020 | STADA
Ad hoc Releases - Stock - Investor Relations | STADA
News - Investor Relations | STADA
Hemofarm - News - STADA's 2021 above-market development strengthens base for further growth, especially in Consumer Healthcare and Specialty
Investor Relations | STADA
IR Contact - Investor Relations | STADA
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Investor
Financial Reports - Investor Relations | STADA
Financial Reports - Investor Relations | STADA
Annual Report 2022 | STADA
Investor Relations | STADA
IR Contact - Investor Relations | STADA
